Back to Search
CARLOS ZARATE, M.D.
M.D.
Psychiatric Hospital Unit
NPI: 1447494554Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder.
PMID 19552485·CNS Drugs·2009
6-review
The role of AMPA receptor modulation in the treatment of neuropsychiatric diseases.
PMID 18291371·Exp Neurol·2008
6-review
Riluzole in psychiatry: a systematic review of the literature.
PMID 18721116·Expert Opin Drug Metab Toxicol·2008
1-meta
Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study.
PMID 17845270·Bipolar Disord·2007
2-rct
A double-blind, placebo-controlled study of memantine in the treatment of major depression.
PMID 16390905·Am J Psychiatry·2006
4-observational
Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder.
PMID 16487491·Biol Psychiatry·2006
6-review
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
PMID 16894061·Arch Gen Psychiatry·2006
4-observational
An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression.
PMID 15705360·Biol Psychiatry·2005
3-trial
An open-label trial of riluzole in patients with treatment-resistant major depression.
PMID 14702270·Am J Psychiatry·2004
3-trial
Pramipexole for bipolar II depression: a placebo-controlled proof of concept study.
PMID 15219473·Biol Psychiatry·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 10 CENTER DR, CRC, UNIT 7 SOUTHEAST, RM. 7-3465
BETHESDA, MD 20892 - Phone
- (301) 451-0861
Quick Facts
- NPI
- 1447494554
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile